Maridebart Cafraglutide
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SW
Amgen · Phase 3 · Recruiting · Enrollment 300
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| MariTide Arm 1 | n/r | n/r | n/r | n/r | n/r |
| MariTide Arm 2 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.